The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1852, Issue 2, 2015, Pages 188-194

  Wang, Changhua ^a   Wang, Xuejun ^a  

^a UNIVERSITY OF SOUTH DAKOTA   (United States)

Author keywords

Autophagy; Heart disease; Proteotoxicity; Ubiquitin proteasome system

Indexed keywords

PROTEASOME; UBIQUITIN; PROTEIN;

ANTIGEN PRESENTATION; AUTOPHAGOSOME; AUTOPHAGY; CARDIOTOXICITY; ENDOPLASMIC RETICULUM STRESS; HEART MUSCLE CELL; HEART PROTECTION; HUMAN; LYSOSOME; MEMBRANE VESICLE; MICROAUTOPHAGY; MISSENSE MUTATION; NONHUMAN; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN INTERACTION; PROTEIN QUALITY; PROTEIN SYNTHESIS; REVIEW; UBIQUITINATION; UNFOLDED PROTEIN RESPONSE; BIOLOGICAL MODEL; DRUG EFFECTS; HEART MUSCLE; METABOLISM; PATHOLOGY;

AUTOPHAGY; HUMANS; MODELS, BIOLOGICAL; MYOCARDIUM; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEINS; UBIQUITIN;

EID: 84919787042     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.07.028     Document Type: Review

References (93)

1. Sandri M., Robbins J. Proteotoxicity: an underappreciated pathology in cardiac disease. J. Mol. Cell. Cardiol. 2014, 71:3-10.
2. Willis M.S., Patterson C. Proteotoxicity and cardiac dysfunction-Alzheimer's disease of the heart?. N. Engl. J. Med. 2013, 368:455-464.
3. Wang X., Robbins J. Proteasomal and lysosomal protein degradation and heart disease. J. Mol. Cell. Cardiol. 2014, 71:16-24.
4. Li J., Horak K.M., Su H., Sanbe A., Robbins J., Wang X. Enhancement of proteasomal function protects against cardiac proteinopathy and ischemia/reperfusion injury in mice. J. Clin. Invest. 2011, 121:3689-3700.
5. Tian Z., Zheng H., Li J., Li Y., Su H., Wang X. Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice. Circ. Res. 2012, 111:532-542.
6. Rajagopalan V., Zhao M., Reddy S., Fajardo G.A., Wang X., Dewey S., Gomes A.V., Bernstein D. Altered ubiquitin-proteasome signaling in right ventricular hypertrophy and failure. Am. J. Physiol. Heart Circ. Physiol. 2013, 305:H551-H562.
7. Tang M., Li J., Huang W., Su H., Liang Q., Tian Z., Horak K.M., Molkentin J.D., Wang X. Proteasome functional insufficiency activates the calcineurin-NFAT pathway in cardiomyocytes and promotes maladaptive remodelling of stressed mouse hearts. Cardiovasc. Res. 2010, 88:424-433.
8. Tannous P., Zhu H., Nemchenko A., Berry J.M., Johnstone J.L., Shelton J.M., Miller F.J., Rothermel B.A., Hill J.A. Intracellular protein aggregation is a proximal trigger of cardiomyocyte autophagy. Circulation 2008, 117:3070-3078.
9. Day S.M. The ubiquitin proteasome system in human cardiomyopathies and heart failure. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H1283-H1293.
10. Sanbe A., Osinska H., Saffitz J.E., Glabe C.G., Kayed R., Maloyan A., Robbins J. Desmin-related cardiomyopathy in transgenic mice: a cardiac amyloidosis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10132-10136.
11. Wang X., Robbins J. Heart failure and protein quality control. Circ. Res. 2006, 99:1315-1328.
12. Wang X., Pattison J.S., Su H. Posttranslational modification and quality control. Circ. Res. 2013, 112:367-381.
13. Pandey U.B., Nie Z., Batlevi Y., McCray B.A., Ritson G.P., Nedelsky N.B., Schwartz S.L., DiProspero N.A., Knight M.A., Schuldiner O., Padmanabhan R., Hild M., Berry D.L., Garza D., Hubbert C.C., Yao T.P., Baehrecke E.H., Taylor J.P. HDAC6 rescues neurodegeneration and provides an essential link between autophagy and the UPS. Nature 2007, 447:859-863.
14. Nedelsky N.B., Todd P.K., Taylor J.P. Autophagy and the ubiquitin-proteasome system: collaborators in neuroprotection. Biochim. Biophys. Acta 2008, 1782:691-699.
15. Zhu K., Dunner K., McConkey D.J. Proteasome inhibitors activate autophagy as a cytoprotective response in human prostate cancer cells. Oncogene 2010, 29:451-462.
16. Lee J.Y., Koga H., Kawaguchi Y., Tang W., Wong E., Gao Y.S., Pandey U.B., Kaushik S., Tresse E., Lu J., Taylor J.P., Cuervo A.M., Yao T.P. HDAC6 controls autophagosome maturation essential for ubiquitin-selective quality-control autophagy. EMBO J. 2010, 29:969-980.
17. Zheng Q., Su H., Tian Z., Wang X. Proteasome malfunction activates macroautophagy in the heart. Am. J. Cardiovasc. Dis. 2011, 1:214-226.
18. Zheng Q., Wang X. Autophagy and the ubiquitin-proteasome system in cardiac dysfunction. Panminerva Med. 2010, 52:9-25.
19. Tian Z., Wang C., Hu C., Tian Y., Liu J., Wang X. Autophagic-lysosomal inhibition compromises ubiquitin-proteasome system performance in a p62 dependent manner in cardiomyocytes. PLoS ONE 2014, 9:e100715.
20. Su H., Li F., Ranek M.J., Wei N., Wang X. COP9 signalosome regulates autophagosome maturation. Circulation 2011, 124:2117-2128.
21. Griffin T.A., Nandi D., Cruz M., Fehling H.J., Kaer L.V., Monaco J.J., Colbert R.A. Immunoproteasome assembly: cooperative incorporation of interferon gamma (IFN-gamma)-inducible subunits. J. Exp. Med. 1998, 187:97-104.
22. Wang X., Terpstra E.J. Ubiquitin receptors and protein quality control. J. Mol. Cell. Cardiol. 2013, 55:73-84.
23. McLendon P.M., Robbins J. Desmin-related cardiomyopathy: an unfolding story. Am. J. Physiol. Heart Circ. Physiol. 2011, 301:H1220-H1228.
24. Bence N.F., Sampat R.M., Kopito R.R. Impairment of the ubiquitin-proteasome system by protein aggregation. Science 2001, 292:1552-1555.
25. Kumarapeli A.R., Horak K.M., Glasford J.W., Li J., Chen Q., Liu J., Zheng H., Wang X. A novel transgenic mouse model reveals deregulation of the ubiquitin-proteasome system in the heart by doxorubicin. FASEB J. 2005, 19:2051-2053.
26. Lindsten K., Menendez-Benito V., Masucci M.G., Dantuma N.P. A transgenic mouse model of the ubiquitin/proteasome system. Nat. Biotech. 2003, 21:897-902.
27. Chen Q., Liu J.B., Horak K.M., Zheng H., Kumarapeli A.R., Li J., Li F., Gerdes A.M., Wawrousek E.F., Wang X. Intrasarcoplasmic amyloidosis impairs proteolytic function of proteasomes in cardiomyocytes by compromising substrate uptake. Circ. Res. 2005, 97:1018-1026.
28. Liu J., Chen Q., Huang W., Horak K.M., Zheng H., Mestril R., Wang X. Impairment of the ubiquitin-proteasome system in desminopathy mouse hearts. FASEB J. 2006, 20:362-364.
29. Liu J., Tang M., Mestril R., Wang X. Aberrant protein aggregation is essential for a mutant desmin to impair the proteolytic function of the ubiquitin-proteasome system in cardiomyocytes. J. Mol. Cell. Cardiol. 2006, 40:451-454.
30. Su H., Li J., Menon S., Liu J., Kumarapeli A.R., Wei N., Wang X. Perturbation of cullin deneddylation via conditional Csn8 ablation impairs the ubiquitin-proteasome system and causes cardiomyocyte necrosis and dilated cardiomyopathy in mice. Circ. Res. 2011, 108:40-50.
31. Ranek M.J., Terpstra E.J., Li J., Kass D.A., Wang X. Protein kinase G positively regulates proteasome-mediated degradation of misfolded proteins. Circulation 2013, 128:365-376.
32. Su H., Li J., Osinska H., Li F., Robbins J., Liu J., Wei N., Wang X. The COP9 signalosome is required for autophagy, proteasome-mediated proteolysis, and cardiomyocyte survival in adult mice. Circ. Heart Fail. 2013, 6:1049-1057.
33. Wang X., Osinska H., Klevitsky R., Gerdes A.M., Nieman M., Lorenz J., Hewett T., Robbins J. Expression of R120G-alphaB-crystallin causes aberrant desmin and alphaB-crystallin aggregation and cardiomyopathy in mice. Circ. Res. 2001, 89:84-91.
34. Wang X., Osinska H., Dorn G.W., Nieman M., Lorenz J.N., Gerdes A.M., Witt S., Kimball T., Gulick J., Robbins J. Mouse model of desmin-related cardiomyopathy. Circulation 2001, 103:2402-2407.
35. Depre C., Wang Q., Yan L., Hedhli N., Peter P., Chen L., Hong C., Hittinger L., Ghaleh B., Sadoshima J., Vatner D.E., Vatner S.F., Madura K. Activation of the cardiac proteasome during pressure overload promotes ventricular hypertrophy. Circulation 2006, 114:1821-1828.
36. Powell S.R., Herrmann J., Lerman A., Patterson C., Wang X. The ubiquitin-proteasome system and cardiovascular disease. Prog. Mol. Biol. Transl. Sci. 2012, 109:295-346.
37. Clague M.J., Urbe S. Ubiquitin: same molecule, different degradation pathways. Cell 2010, 143:682-685.
38. Bulteau A.L., Lundberg K.C., Humphries K.M., Sadek H.A., Szweda P.A., Friguet B., Szweda L.I. Oxidative modification and inactivation of the proteasome during coronary occlusion/reperfusion. J. Biol. Chem. 2001, 276:30057-30063.
39. Divald A., Powell S.R. Proteasome mediates removal of proteins oxidized during myocardial ischemia. Free Radic. Biol. Med. 2006, 40:156-164.
40. Farout L., Mary J., Vinh J., Szweda L.I., Friguet B. Inactivation of the proteasome by 4-hydroxy-2-nonenal is site specific and dependant on 20S proteasome subtypes. Arch. Biochem. Biophys. 2006, 453:135-142.
41. Ishii T., Sakurai T., Usami H., Uchida K. Oxidative modification of proteasome: identification of an oxidation-sensitive subunit in 26S proteasome. Biochemistry 2005, 44:13893-13901.
42. Fielitz J., van Rooij E., Spencer J.A., Shelton J.M., Latif S., van der Nagel R., Bezprozvannaya S., de Windt L., Richardson J.A., Bassel-Duby R., Olson E.N. Loss of muscle-specific RING-finger 3 predisposes the heart to cardiac rupture after myocardial infarction. Proc. Natl. Acad. Sci. U. S. A. 2007, 104:4377-4382.
43. Zhang C., Xu Z., He X.R., Michael L.H., Patterson C. CHIP, a cochaperone/ubiquitin ligase that regulates protein quality control, is required for maximal cardioprotection after myocardial infarction in mice. Am. J. Physiol. Heart Circ. Physiol. 2005, 288:H2836-H2842.
44. Li J., Powell S.R., Wang X. Enhancement of proteasome function by PA28α overexpression protects against oxidative stress. FASEB J. 2011, 25:883-893.
45. Calise J., Powell S.R. The ubiquitin proteasome system and myocardial ischemia. Am. J. Physiol. Heart Circ. Physiol. 2013, 304:H337-H349.
46. Campbell B., Adams J., Shin Y.K., Lefer A.M. Cardioprotective effects of a novel proteasome inhibitor following ischemia and reperfusion in the isolated perfused rat heart. J. Mol. Cell. Cardiol. 1999, 31:467-476.
47. Pye J., Ardeshirpour F., McCain A., Bellinger D.A., Merricks E., Adams J., Elliott P.J., Pien C., Fischer T.H., Baldwin A.S., Nichols T.C. Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H919-H926.
48. Elliott P.J., Zollner T.M., Boehncke W.H. Proteasome inhibition: a new anti-inflammatory strategy. J. Mol. Med. 2003, 81:235-245.
49. Wang X., Su H., Ranek M.J. Protein quality control and degradation in cardiomyocytes. J. Mol. Cell. Cardiol. 2008, 45:11-27.
50. Pattison J.S., Sanbe A., Maloyan A., Osinska H., Klevitsky R., Robbins J. Cardiomyocyte expression of a polyglutamine preamyloid oligomer causes heart failure. Circulation 2008, 117:2743-2751.
51. Kaushik S., Cuervo A.M. Chaperone-mediated autophagy: a unique way to enter the lysosome world. Trends Cell Biol. 2012, 22:407-417.
52. Kiffin R., Christian C., Knecht E., Cuervo A.M. Activation of chaperone-mediated autophagy during oxidative stress. Mol. Biol. Cell 2004, 15:4829-4840.
53. Kaushik S., Massey A.C., Mizushima N., Cuervo A.M. Constitutive activation of chaperone-mediated autophagy in cells with impaired macroautophagy. Mol. Biol. Cell 2008, 19:2179-2192.
54. Nair S., Ren J. Autophagy and cardiovascular aging: lesson learned from rapamycin. Cell Cycle 2012, 11:2092-2099.
55. Lavandero S., Troncoso R., Rothermel B.A., Martinet W., Sadoshima J., Hill J.A. Cardiovascular autophagy: concepts, controversies, and perspectives. Autophagy 2013, 9:1455-1466.
56. Zheng Q., Su H., Ranek M.J., Wang X. Autophagy and p62 in cardiac proteinopathy. Circ. Res. 2011, 109:296-308.
57. Tannous P., Zhu H., Johnstone J.L., Shelton J.M., Rajasekaran N.S., Benjamin I.J., Nguyen L., Gerard R.D., Levine B., Rothermel B.A., Hill J.A. Autophagy is an adaptive response in desmin-related cardiomyopathy. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:9745-9750.
58. Bhuiyan M.S., Pattison J.S., Osinska H., James J., Gulick J., McLendon P.M., Hill J.A., Sadoshima J., Robbins J. Enhanced autophagy ameliorates cardiac proteinopathy. J. Clin. Invest. 2013, 123:5284-5297.
59. Pattison J.S., Osinska H., Robbins J. Atg7 induces basal autophagy and rescues autophagic deficiency in CryABR120G cardiomyocytes. Circ. Res. 2011, 109:151-160.
60. Matsui Y., Takagi H., Qu X., Abdellatif M., Sakoda H., Asano T., Levine B., Sadoshima J. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy. Circ. Res. 2007, 100:914-922.
61. Yan L., Vatner D.E., Kim S.J., Ge H., Masurekar M., Massover W.H., Yang G., Matsui Y., Sadoshima J., Vatner S.F. Autophagy in chronically ischemic myocardium. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:13807-13812.
62. Azad M.B., Chen Y., Henson E.S., Cizeau J., McMillan-Ward E., Israels S.J., Gibson S.B. Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3. Autophagy 2008, 4:195-204.
63. Dosenko V.E., Nagibin V.S., Tumanovska L.V., Moibenko A.A. Protective effect of autophagy in anoxia-reoxygenation of isolated cardiomyocyte?. Autophagy 2006, 2:305-306.
64. Hamacher-Brady A., Brady N.R., Gottlieb R.A. Enhancing macroautophagy protects against ischemia/reperfusion injury in cardiac myocytes. J. Biol. Chem. 2006, 281:29776-29787.
65. Ma X., Liu H., Foyil S.R., Godar R.J., Weinheimer C.J., Hill J.A., Diwan A. Impaired autophagosome clearance contributes to cardiomyocyte death in ischemia/reperfusion injury. Circulation 2012, 125:3170-3181.
66. Ma X., Liu H., Foyil S.R., Godar R.J., Weinheimer C.J., Diwan A. Autophagy is impaired in cardiac ischemia-reperfusion injury. Autophagy 2012, 8:1394-1396.
67. Ma X., Godar R.J., Liu H., Diwan A. Enhancing lysosome biogenesis attenuates BNIP3-induced cardiomyocyte death. Autophagy 2012, 8:297-309.
68. Xie M., Kong Y., Tan W., May H., Battiprolu P.K., Pedrozo Z., Wang Z.V., Morales C., Luo X., Cho G., Jiang N., Jessen M.E., Warner J.J., Lavandero S., Gillette T.G., Turer A.T., Hill J.A. Histone deacetylase inhibition blunts ischemia/reperfusion injury by inducing cardiomyocyte autophagy. Circulation 2014, 129:1139-1151.
69. Rock K.L., Gramm C., Rothstein L., Clark K., Stein R., Dick L., Hwang D., Goldberg A.L. Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell 1994, 78:761-771.
70. Buchberger A., Bukau B., Sommer T. Protein quality control in the cytosol and the endoplasmic reticulum: brothers in arms. Mol. Cell 2010, 40:238-252.
71. Ogata M., Hino S., Saito A., Morikawa K., Kondo S., Kanemoto S., Murakami T., Taniguchi M., Tanii I., Yoshinaga K., Shiosaka S., Hammarback J.A., Urano F., Imaizumi K. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell. Biol. 2006, 26:9220-9231.
72. Groenendyk J., Sreenivasaiah P.K., Kim do H., Agellon L.B., Michalak M. Biology of endoplasmic reticulum stress in the heart. Circ. Res. 2010, 107:1185-1197.
73. Jain K., Suryakumar G., Prasad R., Ganju L. Differential activation of myocardial ER stress response: a possible role in hypoxic tolerance. Int. J. Cardiol. 2013, 168:4667-4677.
74. Yang L., Hu N., Jiang S., Zou Y., Yang J., Xiong L., Ren J. Heavy metal scavenger metallothionein attenuates ER stress-induced myocardial contractile anomalies: role of autophagy. Toxicol. Lett. 2014, 225:333-341.
75. Kouroku Y., Fujita E., Tanida I., Ueno T., Isoai A., Kumagai H., Ogawa S., Kaufman R.J., Kominami E., Momoi T. ER stress (PERK/eIF2alpha phosphorylation) mediates the polyglutamine-induced LC3 conversion, an essential step for autophagy formation. Cell Death Differ. 2007, 14:230-239.
76. Milani M., Rzymski T., Mellor H.R., Pike L., Bottini A., Generali D., Harris A.L. The role of ATF4 stabilization and autophagy in resistance of breast cancer cells treated with Bortezomib. Cancer Res. 2009, 69:4415-4423.
77. Kyrychenko V.O., Nagibin V.S., Tumanovska L.V., Pashevin D.O., Gurianova V.L., Moibenko A.A., Dosenko V.E., Klionsky D.J. Knockdown of PSMB7 induces autophagy in cardiomyocyte cultures: possible role in endoplasmic reticulum stress. Pathobiology 2014, 81:8-14.
78. Dong S., Jia C., Zhang S., Fan G., Li Y., Shan P., Sun L., Xiao W., Li L., Zheng Y., Liu J., Wei H., Hu C., Zhang W., Chin Y.E., Zhai Q., Li Q., Liu J., Jia F., Mo Q., Edwards D.P., Huang S., Chan L., O'Malley B.W., Li X., Wang C. The REGgamma proteasome regulates hepatic lipid metabolism through inhibition of autophagy. Cell Metab. 2013, 18:380-391.
79. Gorbea C., Rechsteiner M., Vallejo J.G., Bowles N.E. Depletion of the 26S proteasome adaptor Ecm29 increases toll-like receptor 3 signaling. Sci. Signal. 2013, 6:ra86.
80. Kopito R.R. Aggresomes, inclusion bodies and protein aggregation. Trends Cell Biol. 2000, 10:524-530.
81. Takalo M., Salminen A., Soininen H., Hiltunen M., Haapasalo A. Protein aggregation and degradation mechanisms in neurodegenerative diseases. Am. J. Neurodegener. Dis. 2013, 2:1-14.
82. Su H., Wang X. Autophagy and p62 in cardiac protein quality control. Autophagy 2011, 7:1382-1383.
83. Zaarur N., Meriin A.B., Bejarano E., Xu X., Gabai V.L., Cuervo A.M., Sherman M.Y. Proteasome failure promotes positioning of lysosomes around the aggresome via local block of microtubule-dependent transport. Mol. Cell. Biol. 2014, 34:1336-1348.
84. Bruning A., Rahmeh M., Friese K. Nelfinavir and bortezomib inhibit mTOR activity via ATF4-mediated sestrin-2 regulation. Mol. Oncol. 2013, 7:1012-1018.
85. Yorimitsu T., Nair U., Yang Z., Klionsky D.J. Endoplasmic reticulum stress triggers autophagy. J. Biol. Chem. 2006, 281:30299-30304.
86. Rapino F., Naumann I., Fulda S. Bortezomib antagonizes microtubule-interfering drug-induced apoptosis by inhibiting G2/M transition and MCL-1 degradation. Cell Death Dis. 2013, 4:e925.
87. Thomas R.L., Roberts D.J., Kubli D.A., Lee Y., Quinsay M.N., Owens J.B., Fischer K.M., Sussman M.A., Miyamoto S., Gustafsson A.B. Loss of MCL-1 leads to impaired autophagy and rapid development of heart failure. Genes Dev. 2013, 27:1365-1377.
88. Cuervo A.M., Palmer A., Rivett A.J., Knecht E. Degradation of proteasomes by lysosomes in rat liver. Eur. J. Biochem. 1995, 227:792-800.
89. Korolchuk V.I., Mansilla A., Menzies F.M., Rubinsztein D.C. Autophagy inhibition compromises degradation of ubiquitin-proteasome pathway substrates. Mol. Cell 2009, 33:517-527.
90. Wang X.J., Yu J., Wong S.H., Cheng A.S., Chan F.K., Ng S.S., Cho C.H., Sung J.J., Wu W.K. A novel crosstalk between two major protein degradation systems: regulation of proteasomal activity by autophagy. Autophagy 2013, 9:1500-1508.
91. Appelqvist H., Waster P., Kagedal K., Ollinger K. The lysosome: from waste bag to potential therapeutic target. J. Mol. Cell Biol. 2013, 5:214-226.
92. Qiao L., Hamamichi S., Caldwell K.A., Caldwell G.A., Yacoubian T.A., Wilson S., Xie Z.L., Speake L.D., Parks R., Crabtree D., Liang Q., Crimmins S., Schneider L., Uchiyama Y., Iwatsubo T., Zhou Y., Peng L., Lu Y., Standaert D.G., Walls K.C., Shacka J.J., Roth K.A., Zhang J. Lysosomal enzyme cathepsin D protects against alpha-synuclein aggregation and toxicity. Mol. Brain 2008, 1:17.
93. Sun M., Ouzounian M., de Couto G., Chen M., Yan R., Fukuoka M., Li G., Moon M., Liu Y., Gramolini A., Wells G.J., Liu P.P. Cathepsin-L ameliorates cardiac hypertrophy through activation of the autophagy-lysosomal dependent protein processing pathways. J. Am. Heart Assoc. 2013, 2:e000191.